{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:29:40Z","timestamp":1794047380934,"version":"4.8.0"},"reference-count":49,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"4","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Anti-T-cell lymphocyte globulin (ATLG) and posttransplant cyclophosphamide (PTCy) are now widely used strategies to prevent graft-versus-host disease (GVHD) after allogeneic stem cell transplantation. Data comparing immune reconstitution (IR) between ATLG and PTCy is scarce. This retrospective study conducted at the University Medical Center Hamburg-Eppendorf (UKE) compares PTCy (n=123) and ATLG (n=476) after myeloablative allogeneic peripheral blood stem cell transplant. Detailed phenotypes of T, B natural killer (NK), natural killer T (NKT) cells were analyzed by multicolor flow at day 30, 100 and 180 posttransplant. Incidence of infections, viral reactivations, GVHD and relapse were collected. Neutrophil engraftment was significantly delayed in the PTCy group (median day 12 vs. day 10, P&lt;0.001) with a high incidence of infection before day+100 in the PTCy arm but a higher Epstein-Barr virus reactivation in the ATLG arm and comparable cytomegalovirus reactivation. Overall incidence of acute GVHD was similar but moderate\/severe chronic GVHD was seen more often after PTCy (44% vs. 38%, P=0.005). ATLG resulted in a faster reconstitution of CD8+ T, NK, NKT and gdT cells while CD4 T cells and B cells reconstituted faster after PTCy. Similar reconstitution was observed for T-regulatory cells and B cells. Non-relapse mortality relapse incidence, disease-free survival, and overall survival did not differ significantly between both arms. Even though differences in IR were related to a decreased incidence of infection and moderate\/severe cGVHD in the ATLG group they had no impact on any of the other long-term outcomes. However, it remains undetermined which regimen is better as GVHD prophylaxis.<\/jats:p>","DOI":"10.3324\/haematol.2020.271445","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T05:20:43Z","timestamp":1617859243000},"page":"857-867","source":"Crossref","is-referenced-by-count":73,"title":["Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease prophylaxis in allogeneic myeloablative peripheral blood stem cell transplantation"],"prefix":"10.3324","volume":"107","author":[{"given":"Radwan","family":"Massoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Gagelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Fritzsche-Friedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaby","family":"Zeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Wolschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Ayuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Christopeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"34538","doi-asserted-by":"crossref","unstructured":"Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006; 354(17):1813-1826.","DOI":"10.1056\/NEJMra052638"},{"key":"34539","doi-asserted-by":"crossref","unstructured":"Horowitz MM, Gale RP, Sondel PM. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990; 75(3):555-562.","DOI":"10.1182\/blood.V75.3.555.555"},{"key":"34540","doi-asserted-by":"crossref","unstructured":"Glucksberg H, Storb R, Fefer A. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974; 18(4):295-304.","DOI":"10.1097\/00007890-197410000-00001"},{"key":"34541","doi-asserted-by":"crossref","unstructured":"Chang YJ, Zhao XY, Huang XJ. Immune reconstitution after haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014; 20(4):440-449.","DOI":"10.1016\/j.bbmt.2013.11.028"},{"key":"34542","doi-asserted-by":"crossref","unstructured":"Roberto A, Castagna L, Zanon V. Role of naive-derived T memory stem cells in Tcell reconstitution following allogeneic transplantation. Blood. 2015; 125(18):2855-2864.","DOI":"10.1182\/blood-2014-11-608406"},{"key":"34543","doi-asserted-by":"crossref","unstructured":"Kanakry CG, O'Donnell PV, Furlong T. Multi-institutional study of post-transplantation cyclophosphamide as singleagent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning. J Clin Oncol. 2014; 32(31):3497-3505.","DOI":"10.1200\/JCO.2013.54.0625"},{"key":"34544","doi-asserted-by":"crossref","unstructured":"Kanakry CG, Tsai HL, Bolanos-Meade J. Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS. Blood. 2014; 124(25):3817-3827.","DOI":"10.1182\/blood-2014-07-587477"},{"key":"34545","doi-asserted-by":"crossref","unstructured":"Jacoby E, Chen A, Loeb DM. Singleagent post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis after human leukocyte antigenmatched related bone marrow transplantation for pediatric and young adult patients with hematologic malignancies. Biol Blood Marrow Transplant. 2016; 22(1):112-118.","DOI":"10.1016\/j.bbmt.2015.08.034"},{"key":"34546","doi-asserted-by":"crossref","unstructured":"Wachsmuth LP, Patterson MT, Eckhaus MA, Venzon DJ, Gress RE, Kanakry CG. Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression. J Clin Invest. 2019; 129(6):2357-2373.","DOI":"10.1172\/JCI124218"},{"key":"34547","doi-asserted-by":"crossref","unstructured":"Kanakry CG, Coffey DG, Towlerton AM. Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide. JCI Insight. 2016; 1(5):e86252.","DOI":"10.1172\/jci.insight.86252"},{"key":"34548","doi-asserted-by":"crossref","unstructured":"Rubio MT, Labopin M, Blaise D. The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2015; 100(5):683-689.","DOI":"10.3324\/haematol.2014.119339"},{"key":"34549","doi-asserted-by":"crossref","unstructured":"Bacigalupo A, Ballen K, Rizzo D. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009; 15(12):1628-1633.","DOI":"10.1016\/j.bbmt.2009.07.004"},{"key":"34550","unstructured":"Przepiorka D, Weisdorf D, Martin P. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995; 15(6):825-828."},{"key":"34551","doi-asserted-by":"crossref","unstructured":"Filipovich AH, Weisdorf D, Pavletic S. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005; 11(12):945-956.","DOI":"10.1016\/j.bbmt.2005.10.001"},{"key":"34552","doi-asserted-by":"crossref","unstructured":"Retiere C, Willem C, Guillaume T. Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation. Oncotarget. 2018; 9(14):11451-11464.","DOI":"10.18632\/oncotarget.24328"},{"key":"34553","doi-asserted-by":"crossref","unstructured":"Horowitz A, Stegmann KA, Riley EM. Activation of natural killer cells during microbial infections. Front Immunol. 2011; 2:88.","DOI":"10.3389\/fimmu.2011.00088"},{"key":"34554","doi-asserted-by":"crossref","unstructured":"Adib-Conquy M, Scott-Algara D, Cavaillon JM, Souza-Fonseca-Guimaraes F. TLRmediated activation of NK cells and their role in bacterial\/viral immune responses in mammals. Immunol Cell Biol. 2014; 92(3):256-262.","DOI":"10.1038\/icb.2013.99"},{"key":"34555","doi-asserted-by":"crossref","unstructured":"Lunemann S, Malone DF, Hengst J. Compromised function of natural killer cells in acute and chronic viral hepatitis. J Infect Dis. 2014; 209(9):1362-1373.","DOI":"10.1093\/infdis\/jit561"},{"key":"34556","doi-asserted-by":"crossref","unstructured":"Hall LJ, Murphy CT, Hurley G. Natural killer cells protect against mucosal and systemic infection with the enteric pathogen Citrobacter rodentium. Infect Immun. 2013; 81(2):460-469.","DOI":"10.1128\/IAI.00953-12"},{"key":"34557","doi-asserted-by":"crossref","unstructured":"Han X, Fan Y, Wang S, Jiao L, Qiu H, Yang X. NK cells contribute to intracellular bacterial infection-mediated inhibition of allergic responses. J Immunol. 2008; 180(7):4621-4628.","DOI":"10.4049\/jimmunol.180.7.4621"},{"key":"34558","doi-asserted-by":"crossref","unstructured":"Nogusa S, Ritz BW, Kassim SH, Jennings SR, Gardner EM. Characterization of agerelated changes in natural killer cells during primary influenza infection in mice. Mech Ageing Dev. 2008; 129(4):223-230.","DOI":"10.1016\/j.mad.2008.01.003"},{"key":"34559","doi-asserted-by":"crossref","unstructured":"Alter G, Martin MP, Teigen N. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR\/HLA subtypes. J Exp Med. 2007; 204(12):3027-3036.","DOI":"10.1084\/jem.20070695"},{"key":"34560","doi-asserted-by":"crossref","unstructured":"Harshan KV, Gangadharam PR. In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice. Infect Immun. 1991; 59(8):2818-2821.","DOI":"10.1128\/iai.59.8.2818-2821.1991"},{"key":"34561","doi-asserted-by":"crossref","unstructured":"Katz P, Yeager H, Whalen G, Evans M, Swartz RP, Roecklein J. Natural killer cellmediated lysis of Mycobacterium-avium complex-infected monocytes. J Clin Immunol. 1990; 10(1):71-77.","DOI":"10.1007\/BF00917500"},{"key":"34562","doi-asserted-by":"crossref","unstructured":"Blanchard DK, Stewart WE 2nd, Klein TW, Friedman H, Djeu JY. Cytolytic activity of human peripheral blood leukocytes against Legionella pneumophila-infected monocytes: characterization of the effector cell and augmentation by interleukin 2. J Immunol. 1987; 139(2):551-556.","DOI":"10.4049\/jimmunol.139.2.551"},{"key":"34563","doi-asserted-by":"crossref","unstructured":"Klimpel GR, Niesel DW, Klimpel KD. Natural cytotoxic effector cell activity against Shigella flexneri-infected HeLa cells. J Immunol. 1986; 136(3):1081-1086.","DOI":"10.4049\/jimmunol.136.3.1081"},{"key":"34564","doi-asserted-by":"crossref","unstructured":"Vantourout P, Hayday A. Six-of-the-best: unique contributions of gd T cells to immunology. Nat Rev Immunol. 2013; 13(2):88-100.","DOI":"10.1038\/nri3384"},{"key":"34565","doi-asserted-by":"crossref","unstructured":"Kalyan S, Kabelitz D. Defining the nature of human gd T cells: a biographical sketch of the highly empathetic. Cell Mol Immunol. 2013; 10(1):21-29.","DOI":"10.1038\/cmi.2012.44"},{"key":"34566","doi-asserted-by":"crossref","unstructured":"Zheng J, Liu Y, Lau Y-L, Tu W. gd-T cells: an unpolished sword in human anti-infection immunity. Cell Mol Immunol. 2013; 10(1):50-57.","DOI":"10.1038\/cmi.2012.43"},{"key":"34567","doi-asserted-by":"crossref","unstructured":"Scheper W, van Dorp S, Kersting S. gdT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia. Leukemia. 2013; 27(6):1328-1338.","DOI":"10.1038\/leu.2012.374"},{"key":"34568","doi-asserted-by":"crossref","unstructured":"Knight A, Madrigal AJ, Grace S. The role of Vd2-negative gd T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. Blood. 2010; 116(12):2164-2172.","DOI":"10.1182\/blood-2010-01-255166"},{"key":"34569","doi-asserted-by":"crossref","unstructured":"Elmaagacli AH, Steckel NK, Koldehoff M. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood. 2011; 118(5):1402-1412.","DOI":"10.1182\/blood-2010-08-304121"},{"key":"34570","doi-asserted-by":"crossref","unstructured":"Perko R, Kang G, Sunkara A, Leung W, Thomas PG, Dallas MH. Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia. Biol Blood Marrow Transplant. 2015; 21(1):130-136.","DOI":"10.1016\/j.bbmt.2014.09.027"},{"key":"34571","doi-asserted-by":"crossref","unstructured":"Lamb L, Gee AP, Hazlett LJ. Influence of T cell depletion method on circulating gd T cell reconstitution and potential role in the graft-versus-leukemia effect. Cytotherapy. 1999; 1(1):7-19.","DOI":"10.1080\/0032472031000141295"},{"key":"34572","doi-asserted-by":"crossref","unstructured":"Godder K, Henslee-Downey P, Mehta J. Long term disease-free survival in acute leukemia patients recovering with increased gd T cells after partially mismatched related donor bone marrow transplantation. Bone Marrow Transplant. 2007; 39(12):751-757.","DOI":"10.1038\/sj.bmt.1705650"},{"key":"34573","doi-asserted-by":"crossref","unstructured":"Salio M, Silk JD, Yvonne Jones E, Cerundolo V. Biology of CD1-and MR1- restricted T cells. Annu Rev immunol. 2014; 32:323-366.","DOI":"10.1146\/annurev-immunol-032713-120243"},{"key":"34574","doi-asserted-by":"crossref","unstructured":"Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol. 2007; 25:297-336.","DOI":"10.1146\/annurev.immunol.25.022106.141711"},{"key":"34575","doi-asserted-by":"crossref","unstructured":"Kim TW, Park S-S, Lim J-Y. Predictive role of circulating immune cell subtypes early after allogeneic hematopoietic stem cell transplantation in patients with acute leukemia. Int J Stem Cell. 2019; 12(1):73-83.","DOI":"10.15283\/ijsc18094"},{"key":"34576","doi-asserted-by":"crossref","unstructured":"Servais S, Menten-Dedoyart C, Beguin Y. Impact of pre-transplant anti-T cell globulin (ATG) on immune recovery after myeloablative allogeneic peripheral blood stem cell transplantation. PLoS One. 2015; 10(6):e0130026.","DOI":"10.1371\/journal.pone.0130026"},{"key":"34577","doi-asserted-by":"crossref","unstructured":"Bosch M, Dhadda M, Hoegh-Petersen M. Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation. Cytotherapy. 2012; 14(10):1258-1275.","DOI":"10.3109\/14653249.2012.715243"},{"key":"34578","doi-asserted-by":"crossref","unstructured":"Toubert A, Glauzy S, Douay C, Clave E. Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again. Tissue Antigens. 2012; 79(2):83-89.","DOI":"10.1111\/j.1399-0039.2011.01820.x"},{"key":"34579","doi-asserted-by":"crossref","unstructured":"Chawla S, Dharmani-Khan P, Liu Y. High serum level of antithymocyte globulin immediately before graft infusion is associated with a low likelihood of chronic, but not acute, graft-versus-host disease. Biol Blood Marrow Transplant. 2014; 20(8):1156-1162.","DOI":"10.1016\/j.bbmt.2014.04.007"},{"key":"34580","unstructured":"Remberger M, Sundberg B. Rabbitimmunoglobulin G levels in patients receiving thymoglobulin as part of conditioning before unrelated donor stem cell transplantation. Haematologica. 2005; 90(7):931-938."},{"key":"34581","doi-asserted-by":"crossref","unstructured":"Pearl JP, Parris J, Hale DA. Immunocompetent T-cells with a memorylike phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant. 2005; 5(3):465-474.","DOI":"10.1111\/j.1600-6143.2005.00759.x"},{"key":"34582","doi-asserted-by":"crossref","unstructured":"Edinger M, Hoffmann P, Ermann J. CD4+ CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med. 2003; 9(9):1144-1150.","DOI":"10.1038\/nm915"},{"key":"34583","doi-asserted-by":"crossref","unstructured":"Nguyen VH, Shashidhar S, Chang DS. The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood. 2008; 111(2):945-953.","DOI":"10.1182\/blood-2007-07-103895"},{"key":"34584","unstructured":"Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny?. Bone Marrow Transplant. 1993; 12(4):387-398."},{"key":"34585","doi-asserted-by":"crossref","unstructured":"Storek J, Dawson MA, Storer B. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood. 2001; 97(11):3380-3389.","DOI":"10.1182\/blood.V97.11.3380"},{"key":"34586","doi-asserted-by":"crossref","unstructured":"Small TN, Keever CA, Weiner-Fedus S, Heller G, O'Reilly RJ, Flomenberg N. B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood. 1990; 76(8):1647-1656.","DOI":"10.1182\/blood.V76.8.1647.bloodjournal7681647"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2020.271445\/73236","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2020.271445\/74281","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10233\/73236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:59:23Z","timestamp":1794045563000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2020.271445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2020.271445","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,8]]}}}